Jun 20, 2025
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.56 to $0.06.
The split itself did not change the total investment value.
Unicycive Therapeutics, Inc. (UNCY) trades on the NASDAQ Capital Market in the Biotechnology industry.
Unicycive Therapeutics, Inc. company overviewThe latest split shown was on June 20, 2025. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
This history records one reverse split, on June 20, 2025.